Quantinuum (NASDAQ:QNT) Given New $65.00 Price Target at Jefferies Financial Group

Quantinuum (NASDAQ:QNT) had its price objective dropped by analysts at Jefferies Financial Group from $85.00 to $65.00 in a research report issued on Friday, Benzinga reports. The firm presently has a “buy” rating on the stock. Jefferies Financial Group‘s price target indicates a potential upside of 73.01% from the stock’s previous close.

Several other equities analysts have also recently issued reports on QNT. Yorkville Ives assumed coverage on shares of Quantinuum in a research note on Monday, October 5th. They set an “outperform” rating and a $60.00 target price on the stock. Needham & Company LLC reduced their price target on shares of Quantinuum from $100.00 to $60.00 and set a “buy” rating for the company in a research note on Friday. Sanford C. Bernstein reiterated a “hold” rating on shares of Quantinuum in a research note on Wednesday, August 12th. Morgan Stanley raised shares of Quantinuum from an “equal weight” rating to an “overweight” rating and decreased their price objective for the company from $78.00 to $62.00 in a report on Thursday, October 15th. Finally, Cantor Fitzgerald lowered their price objective on shares of Quantinuum from $90.00 to $55.00 and set an “overweight” rating on the stock in a research report on Friday. Thirteen analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $85.62.

Quantinuum Stock Performance

Shares of QNT stock traded up $7.75 during mid-day trading on Friday, hitting $37.57. The company’s stock had a trading volume of 5,036,156 shares, compared to its average volume of 2,310,231. The firm has a market capitalization of $9.89 billion and a PE ratio of -134.18. Quantinuum has a 52-week low of $28.31 and a 52-week high of $86.79. The company has a 50-day moving average of $43.41.

Quantinuum (NASDAQ:QNT) last released its quarterly earnings data on Thursday, November 5th. The company reported ($0.29) EPS for the quarter, beating the consensus estimate of ($0.99) by $0.70. The business had revenue of $9.05 million for the quarter. As a group, equities research analysts predict that Quantinuum will post -4.76 EPS for the current fiscal year.

Institutional Trading of Quantinuum

A number of hedge funds have recently bought and sold shares of the company. CoreCap Advisors LLC bought a new position in Quantinuum in the third quarter valued at about $32,000. Fifth Third Bancorp grew its stake in shares of Quantinuum by 1,530.2% during the 3rd quarter. Fifth Third Bancorp now owns 1,027 shares of the company’s stock valued at $49,000 after purchasing an additional 964 shares during the period. IFP Advisors Inc grew its stake in shares of Quantinuum by 1,150.0% during the 3rd quarter. IFP Advisors Inc now owns 1,250 shares of the company’s stock valued at $60,000 after purchasing an additional 1,150 shares during the period. Steel Grove Capital Advisors LLC grew its stake in shares of Quantinuum by 25.6% during the 3rd quarter. Steel Grove Capital Advisors LLC now owns 5,992 shares of the company’s stock valued at $288,000 after purchasing an additional 1,222 shares during the period. Finally, Russell Investments Group Ltd. purchased a new stake in shares of Quantinuum during the 3rd quarter valued at about $97,000.

Quantinuum News Summary

Here are the key news stories impacting Quantinuum this week:

• Positive Sentiment: Quantinuum beat third-quarter expectations, reporting a loss of $0.29 per share versus the $0.99 loss analysts expected. Revenue rose 233% year over year to $9.05 million, and the company raised its full-year 2026 revenue outlook. The report also noted that gross margin turned positive, although expenses are increasing. Quantinuum Q3 results and outlook
• Positive Sentiment: Commercial traction strengthened: Quantinuum said it secured its largest cloud agreement to date, expanded access through a hyperscaler and an Oracle beta launch, and saw platform adoption rise nearly 20% quarter over quarter. These developments could help build future revenue. Quantinuum Q3 results and outlook
• Positive Sentiment: The company outlined its Nexus developer-platform roadmap, connecting application development with future hardware, including its planned Apollo fault-tolerant quantum computer. The roadmap and reported technical milestones could strengthen Quantinuum’s longer-term competitive position. Nexus roadmap announcement
• Negative Sentiment: Some analysts lowered their forecasts and price targets after the results. Cantor Fitzgerald cut its target from $90 to $55 and Needham lowered its target from $100 to $60, though both retained positive ratings—Overweight and Buy, respectively. The cuts may temper enthusiasm despite the earnings beat. Analysts cut forecasts after Q3 results

About Quantinuum

Quantinuum is a quantum computing company formed in 2021 through the combination of Honeywell Quantum Solutions and Cambridge Quantum. The company develops full-stack quantum computing technologies designed to support research and commercial applications across industries, including chemistry, materials science, cybersecurity, finance and artificial intelligence.

Its offerings include trapped-ion quantum computers, quantum software and development tools. Quantinuum’s software portfolio includes the TKET quantum compiler, InQuanto quantum chemistry platform, Quantum Origin quantum-enhanced cybersecurity solutions and the Nexus platform for developing and managing quantum applications.